Victoria Dinkel

Pyrazolopyridine Inhibitors of B-Raf^V600E. Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors

Steve Wenglowsky, Li Ren, Kateri A. Ahrendt et al. · ACS Medicinal Chemistry Letters · 2011 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

Abstract 852: ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice

Victoria Dinkel, Deborah Anderson, Shannon L. Winski et al. · Cancer Research · 2012 · 48 citations

Medicine, Oncology, Pharmacology +14

Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties

Simon Mathieu, Stefan Gradl, Li Ren et al. · Journal of Medicinal Chemistry · 2012 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-RafV600E kinase with favorable physicochemical and pharmacokinetic properties

Li Ren, Ellen R. Laird, Alex J. Buckmelter et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase

Steve Wenglowsky, Li Ren, Jonas Grina et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11